by Typhoid fever vaccines are used for immunizing humans against typhoid fever caused by Salmonella Typhi bacteria. Typhoid fever is a bacterial infection spread through contaminated food or water. The vaccines offer safe, long-lasting protection against the disease. Oral typhoid vaccines containing live but weakened Salmonella Typhi germs help the body develop immunity against typhoid fever after being introduced to a form of the bacteria that cannot cause disease. Injectable typhoid vaccines contain ingredients derived from Salmonella Typhi bacteria that help develop targeted immune response.
The global typhoid fever vaccines market is estimated to be valued at US$ 454.2 Bn in 2024 and is expected to exhibit a CAGR of 14% over the forecast period from 2024 to 2030.
Key Takeaways
Key players operating in the typhoid fever vaccines market:
Key players operating in the typhoid fever vaccines market are Linde Plc, Air Liquide, Engie, Uniper Se, Air Products Inc, Clean Hydrogen System, Cummins Inc., Toshiba Energy Systems & Solutions Corporation, Nel Asa, and Sgh2 Energy.
Key opportunities in typhoid fever vaccines market:
Rising awareness about typhoid prevention through vaccination and increasing government support for immunization programs in developing regions offer lucrative opportunities in the typhoid fever vaccines market. Development of affordable typhoid conjugate vaccines with longer lasting protection also presents opportunities for key players.
Global expansion of typhoid fever vaccines market:
With increasing global prevalence of typhoid fever, especially in low and middle-income countries marked by poor sanitation and limited access to clean drinking water, leading manufacturers are emphasizing on expanding their product reach and availability in these growing regional markets. Partnerships with governmental and non-governmental organizations support global expansion plans of players.
Market drivers
Rising prevalence of typhoid fever cases globally is a major market driver. As per WHO estimates, over 11 million cases of typhoid fever occur annually resulting in over 100,000 deaths worldwide. Increased international travel and population migration have further boosted global spread of the disease. With no permanent immunity provided by previous infections or vaccines, recurrent demand for prevention through vaccination contributes to long-term market growth.
PEST Analysis
Political: The Typhoid Fever Vaccines Market Growth is regulated by government and health organizations to ensure safety and efficacy of the vaccines. Stringent regulations are enforced for approval and administration of vaccines.
Economic: Developing nations report the highest incidence of typhoid. Thus aid from development agencies along with government subsidy programs help increase accessibility and adoption of typhoid vaccines.
Social: Growing awareness about preventing typhoid through vaccination along with initiatives by non-profits help increase the social acceptance and demand for typhoid vaccines.
Technological: Research into new vaccine formulations, production technologies and vaccination delivery methods help improve efficacy, ease of administration and reduce costs. This also helps in expanding vaccination programs.
Geographical concentration
The Asia Pacific region accounts for the largest market share in terms of value. Developing nations like India, China, Pakistan report highest incidences of typhoid resulting in larger vaccine adoption in this region. Sub-Saharan Africa is another major region concentrated in terms of typhoid fever disease burden and vaccination programs.
Fastest growing region
Latin America is expected to emerge as the fastest growing region for the typhoid fever vaccines market during the forecast period. Increasing awareness, socio-economic development and government initiatives are driving higher vaccination rates in countries like Brazil and Mexico.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
